Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
about
Immune Mechanisms in Myelodysplastic SyndromeMissing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodMesenchymal stem cells in pathogenesis of myelodysplastic syndromesIn-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their InteractionsHDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?Myelodysplasia is in the niche: novel concepts and emerging therapies.Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow.MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometryDigging deep into "dirty" drugs - modulation of the methylation machinery.Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.The hematopoietic stem-cell niche in health and leukemia.Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes.Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.Epigenetics of myelodysplastic syndromes.Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients.The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.Myeloid malignancies and the microenvironment.Mesenchymal stromal cells in myeloid malignancies.Decreased AGO2 and DCR1 in PBMCs from War Veterans with PTSD leads to diminished miRNA resulting in elevated inflammation.Let-7 microRNA-dependent control of leukotriene signaling regulates the transition of hematopoietic niche in mice.Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence.Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms.Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.Role of the microenvironment in myeloid malignancies.The bone-marrow niche in MDS and MGUS: implications for AML and MM.Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.Breed-specific expression of DROSHA, DICER and AGO2 is regulated by glucocorticoid-mediated miRNAs in the liver of newborn piglets.Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
P2860
Q26744500-8BB283CD-D772-441B-86AD-B73280B2777BQ26798389-91D54CF6-EC57-4346-8A6A-BB74E42EF2A3Q27011323-20A4AFCE-EA39-4198-BAB6-01093C6035B5Q28707993-52529756-C2C1-4C08-AB5F-E55A8FF5045CQ33709629-D4116C5A-F082-4222-B414-3DD06022DEC9Q35059425-23221F82-2E9D-4AC9-973A-6CFA47A89787Q35911998-9AC3FE39-CA50-4B1A-AA53-CE9A1A21263EQ36034814-7EDC45C7-F18A-4BA7-B74E-C83BE8C4FD42Q36454220-FBC0021B-8A41-4C52-A1B0-E658549D8677Q36523796-1AE135A5-DDA6-4C04-910A-51CEA5D4BE4AQ36715982-36AEF09B-A40E-4814-871F-88B840E6E9D5Q37610816-CCF4EB5F-4C1B-4348-9528-895D3DCCAA5BQ38113961-725F8DA2-04E2-4015-900B-6D3999FF89DCQ38139915-4B8D526A-0BA3-4237-A123-31E3B78FAE9FQ38163846-0B857493-AE58-4391-B349-5B35ED39F27EQ38175397-47C790CF-92B7-4867-A3B0-897D1227995BQ38294212-CE90F8F2-1215-4210-9C56-402C551C4F1AQ38604716-7AD545BE-692B-4510-9A83-E59AB302520FQ38615755-AE257A52-4B3D-4BD6-820F-D8826B326474Q38880958-3E5C517B-DA1A-48FF-AD49-15418766AD0BQ39073878-620A700D-3839-4113-9FE6-DD0C37A03F8FQ39090002-4F720FB8-202E-4937-8E38-FB45C4F83CD5Q40066763-526169FE-4793-42A4-A69E-C8BF5C1A18DEQ41124895-925EEDAA-1B92-4242-B22E-1362EFF5D594Q41205103-9F4D1DF2-174B-47C0-8F32-8731234B818BQ42190228-30B40C44-20F2-4737-91C0-1603F2728B53Q44998014-2B9CF2FA-7149-4DDE-9DD5-3F7E16C6ABBFQ49986947-7C20F466-52CE-4E8A-841E-56CC9F704570Q50114615-3695C1AD-2CFC-462A-B39A-2C3705163809Q52717549-A3F58529-7123-400B-B5A1-9DCF80DB9172Q54314702-B2B80094-D712-4460-93C1-1E0A3617502DQ54348216-0675A0B4-E35F-424C-8102-F25B1C4DC996
P2860
Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impaired expression of DICER, ...... lodysplastic syndrome patients
@ast
Impaired expression of DICER, ...... lodysplastic syndrome patients
@en
type
label
Impaired expression of DICER, ...... lodysplastic syndrome patients
@ast
Impaired expression of DICER, ...... lodysplastic syndrome patients
@en
prefLabel
Impaired expression of DICER, ...... lodysplastic syndrome patients
@ast
Impaired expression of DICER, ...... lodysplastic syndrome patients
@en
P2093
P2860
P1433
P1476
Impaired expression of DICER, ...... lodysplastic syndrome patients
@en
P2093
Beatriz Rosón
Belén Blanco
Carlos Santamaría
Fermín M Sánchez-Guijo
Jesús F San Miguel
Marcos González
María Consuelo Del Cañizo
María Díez-Campelo
Olga López-Villar
Sandra Muntión
P2860
P304
P356
10.3324/HAEMATOL.2011.054437
P577
2012-02-27T00:00:00Z